Innofactor Plc: Share Repurchase 28.2.2023
| Innofactor Plc | Announcement 28.2.2023 | |
| Innofactor Plc: Share Repurchase 28.2.2023 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 28.2.2023 | |
| Bourse trade | Buy | |
| Share | IFA1V | |
| Amount | 4,924 | Shares |
| Average price/ share | 1.2800 | EUR |
| Total cost | 6,302.72 | EUR |
| Innofactor Plc now holds a total of 1 491 410 shares | ||
| including the shares repurchased on 28.2.2023 | ||
| On behalf of Innofactor Plc | ||
| Nordea Bank Oyj | ||
| Janne Sarvikivi | Sami Huttunen | |
| Additional information: | ||
| Sami Ensio, CEO | ||
| Innofactor Plc | ||
| Tel. +358 50 584 2029 | ||
| sami.ensio@innofactor.com | ||
| www.innofactor.com | ||
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS3.5.2024 10:05:00 CEST | Press release
Auction date2024-05-03Loan1059Coupon1.00 %ISIN-codeSE0007125927Maturity2026-11-12Tendered volume, SEK mln1,000 +/- 1,000Total bid volume, SEK mln3,100 Volume sold, SEK mln1,000 Number of bids9 Number of accepted bids1 Average yield2.831 %Lowest yield2.831 %Highest accepted yield2.831 %% accepted at highest yield 100.00 Auction date2024-05-03Loan1063Coupon0.50 %ISIN-codeSE0015193313Maturity2045-11-24Tendered volume, SEK mln900 +/- 900Total bid volume, SEK mln3,492 Volume sold, SEK mln900 Number of bids37 Number of accepted bids8 Average yield2.526 %Lowest yield2.517 %Highest accepted yield2.529 %% accepted at highest yield 11.63
Danske Bank A/S, transactions by persons discharging managerial responsibilities3.5.2024 10:02:35 CEST | Press release
3 May 2024 Notification no. 46/2024 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back program in Danske Bank A/S, APMH Invest A/S continuously sells shares pro rata. For further details, please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. Contact: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Attachment APMH Invest AS - sale - 2024.05.02
Danske Bank A/S, ledende medarbejderes transaktioner3.5.2024 10:02:35 CEST | pressemeddelelse
3. maj 2024 Indberetning nr. 46/2024 Ændring i aktiebesiddelser hos Danske Banks indberetningspligtige i henhold til EU-forordningen om markedsmisbrug I forbindelse med Danske Bank A/S’ aktietilbagekøbsprogram sælger APMH Invest A/S løbende aktier i Danske Bank A/S pro rata. For yderligere detaljer henvises til de vedhæftede skemaer, hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres. Kontakt: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Vedhæftet fil APMH Invest A_S - salg - 2024.05.02
PCI Biotech Holding ASA - Notice of Annual General Meeting 20243.5.2024 10:00:00 CEST | Press release
Oslo, Norway 3 May 2024 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 24 May 2024 at 10:00am (CEST). The notice and proposed resolutions to the annual general meeting are attached. The notice, including all appendices, will be made available at PCI Biotech's corporate website www.pcibiotech.com. For further information, please contact: Ronny Skuggedal, CEO/CFO, E-mail: rs@pcibiotech.no Office: +47 67 11 54 00 Mobile: +47 94 00 57 57 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachments PCI Biotech Innkalling GF 2024PCI Biotech Forslag til beslutninger GF 2024PCI Biotech Notice of AGM 2024PCI Biotech Proposed resolutions for the AGM 2024
Oma Savings Bank Plc: The Finnish Financial Supervisory Authority (FIN-FSA) has made a preliminary investigation request to the police3.5.2024 09:55:00 CEST | Press release
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 3 MAY 2024 AT 10:55 A.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGE Oma Savings Bank Plc: The Finnish Financial Supervisory Authority (FIN-FSA) has made a preliminary investigation request to the police Oma Savings Bank Plc (OmaSp or the Company) has been informed that the Finnish Financial Supervisory Authority (FIN-FSA) has made a preliminary investigation request to the police for securities market offences related to the Company. At the same time, the Finnish Financial Supervisory Authority (FIN-FSA) has said that it will investigate the need to impose administrative sanctions on the Company. In addition, the Finnish Financial Supervisory Authority states in its announcement that the Company's financial situation is stable, and it has good liquidity and capital adequacy. The Company operates under the supervision of the Finnish Financial Supervisory Authority (FIN-FSA). OmaSp will work in full cooperation with the auth